R&D Views & Analysis | pharmaphorum

Views & Analysis

How AI is fighting COVID-19: the companies using intelligent...

The use of artificial intelligence (AI) in drug development has been hyped up for some time now – and the COVID-19 pandemic is finally a chance for these technologies to prove their worth.

Views & Analysis

Coronavirus pharma news roundup – 24/04/2020

Research into drugs that could treat or prevent COVID-19 continued full steam ahead this week as the industry puts all its resources into fighting the coronavirus pandemic.

Views & Analysis

Coronavirus vaccine: how pharma is picking up the pace

The world is waiting with bated breath for a coronavirus vaccine, which has become one of the most sought-after pharmaceutical products of the last century.

Views & Analysis

Stickers with a coronavirus and a question mark. The concept of unforeseen results from the coronavirus. News, articles, newspapers.

Coronavirus pharma news roundup – 17/04/20

As Europe and the US mooted easing lockdown restrictions this week, pharma ramped up its testing of vaccines and antiviral drugs – but there are signs that the virus is starting to bite int

Views & Analysis

National Minority Health Month: the importance of diversity ...

Most health conditions do not discriminate based on race, color, gender or identity. However, background and identity can make access to health treatment much more difficult.

Views & Analysis